Clinical Need

Therapeutic advances in both electrophysiology and structural heart procedures present new challenges in procedural guidance underserved by current methods of imaging.

Real-time 3D (4D) imaging plays a critical role in the adoption of increasingly complex structural heart procedures. To guide LAA closure, mitral valve repair, and tricuspid valve repair procedures, physicians currently rely on 4D TEE which requires a dedicated echocardiographer to navigate the TEE probe and generate the cardiac images.

4D imaging on an ICE platform puts control of the image generation in the hands of interventionalist, allowing him/her to guide the imaging catheter throughout the procedure. In addition, 4D ICE allows structural heart procedures to be performed under conscious sedation and offers potential cost savings.

In the United States, 2D ICE is currently used in ~85% of electrophysiology (EP) ablation cases. As EP ablation technologies continue to evolve and procedures become increasingly complex, there is a growing need for advanced intracardiac imaging beyond the capabilities of traditional 2D ICE.

4D ICE offers all of the imaging capabilities of 2D ICE with the added spatial benefits of real-time intracardiac 3D guidance. This enhanced visualization allows physicians to better assess complex cardiac structures with the potential to improve outcomes and reduce procedure times and fluoroscopy exposure.

  • Features all imaging modes and advanced visualization tools associated with 4D ultrasound
  • Delivers a large field of view and fast frame rates with outstanding image quality as a result of hundreds of transmitting and receiving elements
  • Works with conventional ultrasound systems due to highly specialized application specific integrated circuit (ASIC)
  • Wide 90º X 90º field-of-view
  • Independent distal tip rotation for optimal user-controlled transducer orientation and telescoping distal tip
  • Facilitates femoral vein access which enables conscious sedation

See it in Action

Mitral Valve, 4D from Left Atrium

Mitral Valve, Multi-plane from Left Atrium
Mitral Valve, 4D from Right Atrium
Tricupsid Valve post MitraClip, 4D

Company

NuVera Medical, Inc., a portfolio company of Shifamed, LLC., is enabling a new era in transcatheter cardiac interventions through the advancement of real-time 3D intracardiac echocardiography (4D ICE).

Leadership Team

Todor Jeliaskov

President and CEO

David Voris

Chief Financial Officer

Larry Hu

Senior VP, R&D

Robert Nardelli

VP, Regulatory Affairs & QA

Alan Schaer

VP, Advanced Development

Katie Arnold

Marketing Strategy Consultant

Amr Salahieh

Chairman of the Board

Mariam Maghribi

Chief Business Officer, Shifamed

Debbie White

VP, HR & Administration, Shifamed

Robert Edesess

VP, Intellectual Property, Shifamed

Laura Minarsch

Clinical Consultant

Career Opportunities

Current Openings

To learn more or if you are interested in applying, please submit your resume to hr@nuveramedical.com.

Description here.

There are no current openings, please check back soon.

News

NuVera Medical Raises New Financing

February 9th, 2019|

CAMPBELL, CA – NuVera Medical Inc., a portfolio company of Shifamed LLC, announced today it completed the first closing of a $15 million financing round led by Cormorant Asset Management with continued participation from the Capital Partnership, Lilly Asia Ventures, and other existing shareholders.

NuVera Medical Closure of $11M in Series A Financing

August 29th, 2017|

CAMPBELL, CA — NuVera Medical, Inc., a portfolio company of Shifamed, LLC., announced today it has raised $11M in Series A financing. The financing, which closed on June 28, 2017, was led by The Capital Partnership with participation from GE Ventures, Lilly Asia Ventures, and Cormorant Asset Management.

Contact

NuVera Medical

590 Division Street
Campbell, CA 95008

Tel: 408-560-2500

Follow Us

Clinical Need

Therapeutic advances have presented new challenges which are underserved by current methods of imaging.

Real-time 3D (4D) imaging plays a critical role in the adoption of increasingly complex structural heart procedures. To guide LAA closure, mitral valve repair, and tricuspid valve repair procedures, physicians currently rely on 4D TEE which requires a dedicated echocardiographer to navigate the TEE probe and generate the cardiac images.
4D imaging on an ICE platform puts control of the image generation in the hands of interventionalist, allowing him/her to guide the imaging catheter throughout the procedure. In addition, 4D ICE allows structural heart procedures to be performed under conscious sedation and offers potential cost savings.
In the United States, 2D ICE is currently used in ~85% of electrophysiology (EP) ablation cases. As EP ablation technologies continue to evolve and procedures become increasingly complex, there is a growing need for advanced intracardiac imaging beyond the capabilities of traditional 2D ICE.
4D ICE offers all of the imaging capabilities of 2D ICE with the added spatial benefits of real-time intracardiac 3D guidance. This enhanced visualization allows physicians to better assess complex cardiac structures with the potential to improve outcomes and reduce procedure times and fluoroscopy exposure.
  • Features all imaging modes and advanced visualization tools associated with 4D ultrasound
  • Delivers a large field of view and fast frame rates with outstanding image quality as a result of hundreds of transmitting and receiving elements
  • Works with conventional ultrasound systems due to highly specialized application specific integrated circuit (ASIC)
  • Wide 90º X 90º field-of-view
  • Independent distal tip rotation for optimal user-controlled transducer orientation and telescoping distal tip
  • Facilitates femoral vein access which enables conscious sedation

See it in Action

Mitral Valve, 4D from Left Atrium

Mitral Valve, Multi-plane from Left Atrium

Mitral Valve, 4D from Right Atrium

Tricupsid Valve post MitraClip, 4D

Company

NuVera Medical, Inc., a portfolio company of Shifamed, LLC., is enabling a new era in transcatheter cardiac interventions through the advancement of real-time 3D intracardiac echocardiography (4D ICE).

Leadership Team

Todor Jeliaskov

President and CEO

David Voris

Chief Financial Officer

Larry Hu

Senior VP, R&D

Robert Nardelli

VP, Regulatory Affairs & QA

Alan Schaer

VP, Advanced Development

Katie Arnold

Marketing Strategy Consultant

Amr Salahieh

Chairman of the Board

Mariam Maghribi

Chief Business Officer, Shifamed

Debbie White

VP, HR & Administration, Shifamed

Robert Edesess

VP, Intellectual Property, Shifamed

Laura Minarsch

VP, Intellectual Property, Shifamed

Career Opportunities

Current Openings

To learn more or if you are interested in applying, please submit your resume to hr@nuveramedical.com.

There are no current openings, please check back soon.

News

NuVera Medical Raises New Financing

February 9th, 2019|

CAMPBELL, CA – NuVera Medical Inc., a portfolio company of Shifamed LLC, announced today it completed the first closing of a $15 million financing round led by Cormorant Asset Management with continued participation from the Capital Partnership, Lilly Asia Ventures, and other existing shareholders.

NuVera Medical Closure of $11M in Series A Financing

August 29th, 2017|

CAMPBELL, CA — NuVera Medical, Inc., a portfolio company of Shifamed, LLC., announced today it has raised $11M in Series A financing. The financing, which closed on June 28, 2017, was led by The Capital Partnership with participation from GE Ventures, Lilly Asia Ventures, and Cormorant Asset Management.

Contact

NuVera Medical

590 Division Street Campbell, CA 95008

Tel: 408-560-2500

Follow Us